Endocrine system
6.1.1.1 short-acting insulins
First line: Insulin aspart (NovoRapid®) human soluble insulin (Actrapid®)
Alternatives: human soluble insulin (Humulin S®),
Second line options: insulin glulisine (Apidra®), insulin lispro (Humalog®)
6.1.1.2 intermediate and long acting insulins
Human long-acting insulins
First line: insulin glargine (Lantus®)
Alternative: insulin detemir (Levemir®)
Human isophane insulins
options: Human Insulatard, Humulin I®
Human biphasic insulins
First line options: Biphasic insulin aspart (Humulin M3®, NovoMix 30®)
Second line options: Biphasic insulin lispro (Humalog Mix 25®, Humalog Mix 50®)
Type II diabetes human insulin guidelines
6.1.2.1 Sulphonylureas
First line: gliclazide
Second line options: glimepiride, glipizide, gliclazide MR
For specialist use only: tolbutamide
6.1.2.2 Biguanides
First line: metformin
Second line: metformin m/r
6.1.2.3 Other antidiabetic drugs
First line: pioglitazone, sitagliptin, saxagliptin
Second line: acarbose, vildagliptin
For specialist initiation only: exenatide (including m/r), liraglutide, lixisenatide
shared care guideline for exenatide, including m/r and liraglutide
shared care guideline to be updated and categorisation to be reviewed
6.1.4 Treatment of hypoglycaemia
First line: GlucoGel®, Dextrogel®, Glucagen Hypokit®
For hospital initiation only: diazoxide
6.1.6 Diagnosis and monitoring devices for diabetes mellitus
Blood glucose monitoring options: Aviva®, Contour®, One Touch®, Optimum Plus®.
Urinalysis options: Clinistix®, Ketostix®
Glucose tolerance test: Polycal liquid®
6.2.1 Thyroid hormones
First line: levothyroxine sodium
For hospital use only: liothyronine sodium
6.2.2 Antithyroid drugs
First line: carbimazole
For use in pregnancy: propylthiouracil
For hospital use only: radioactive iodine-131 capsules, aqueous iodine oral solution (Lugol's solution®)
6.3.1 Replacement therapy
fludrocortisone
6.3.2 Glucocorticoid therapy
First line: prednisolone
Second line: betamethasone, hydrocortisone, methylprednisolone, prednisolone e/c, triamcinolone
For specific indications only: dexamethasone
6.4.1.1 Oestrogens and HRT
Conjugated oestrogens with progestogen
First line: Prempak-C®, Premique®
Estradiol with progestogen:
First line: Elleste-Duet®, Evorel Conti®, Femapak®, Femseven Conti®, Kliofem®, Kliovance®
Second line: Climagest®, Elleste-Duet Conti®, Evorel Sequi®, Femoston®, FemSeven Sequi®
Conjugated oestrogens only:
First line: Elleste-Solo®, Evorel®, FemSeven®, Oestrogel®
Second line: Elleste Solo MX®, Climaval®, Premarin®
Short-term treatment of oestrogen deficiency
tibolone
Treatment and prevention of postmenopausal osteoporosis
raloxifene
6.4.1.2 Progestogens
First line options: medroxyprogesterone acetate, norethisterone, progesterone
For hopsital use only: ulipristal acetate (Esmya®)
6.4.2 Male sex hormones and antagonists
Testosterone and esters:
First line: testosterone gel
For hospital initiation only: testosterone implant, testosterone injection im
For hypoactive sexual desire disorder associated with surgically induced menopause: testosterone patch (Intrinsa®)
Anti-androgens:
First line: cyproterone, finasteride
Second line: dutasteride
6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens
Anti-oestrogens:
clomifene
Corticotrophins:
For hospital use only: tetracosactide
Gonadotrophins:
For hospital use only: chorionic gonadotrophin, follitropin alfa and beta, urofollitrophin
Growth hormone:
For hospital use only: somatropin
Commissioning statement on the use of growth hormone in children and adults
Growth hormone receptor antagonists:
For hospital use only: pegvisomant
Hypothalmic hormones:
For hospital use only: gonadorelin
6.5.2 Posterior pituitary hormones and antagonists
For hospital initiation only: desmopressin
For hospital use only: terlipressin, vasopressin
Antidiuretic hormone antagonists:
First line: demeclocycline
6.6.1 Calcitonin and parathyroid hormones
calcitonin (salmon) for prevention of acute bone loss due to sudden immobility
For hospital use only: calcitonin (salmon) for hypercalcaemia of malignancy, parathyroid hormone, teriparatide
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
For osteoporosis
First line: alendronic acid
Second line: risedronate, ibandronic acid, disodium etidronate
Third line: strontium ranelate, denosumab
For hospital initiation: IV zoledronic acid
- shared care guideline for denosumab for the prevention of fragility fractures
- medical management of osteoporosis
- management of glucocorticoid-induced osteoporosis
- long term use of bisphosphonates
Reduction of bone damage in bone metastases in breast cancer
First line: oral ibandronate
Second line: denosumab
- shared care guideline for denosumab for the prevention of skeletal-related events
- NICE TA 265 denosumab
For Paget's disease
Risedronate
Other indications
For hospital use only according to licensed indication: disodium pamidronate, sodium clodronate
6.7.1 Bromocriptine and other dopaminergic drugs
First line: bromocriptine
Second line: cabergoline
6.7.2 Drugs affecting gonadotrophins
First line: danazol
Gonadorelin analogues:
First line options in accordance with licence: goserelin, leuprorelin acetate, triptorelin
For hospital use only: buserelin, nafarelin
6.7.3 Metyrapone and trilostane
